Table 2.
Cumulative incidence of CHF and log-rank comparison adjusted for competing risk of death
Cumulative incidence |
||||
---|---|---|---|---|
5-year | 10-year | 15-year | P | |
Entire cohort | 4.8% | 6.8% | 9.1% | |
By sex | ||||
Male | 2.7% | 5.0% | 6.7% | <.01 |
Female | 7.6% | 9.4% | 12.1% | |
By sex and diagnosis * | ||||
Male, nonlymphoma | 3.8% | 5.5% | 8.8% | <.01 |
Female, nonlymphoma | 6.0% | 6.0% | 6.0% | |
Male, lymphoma | 2.2% | 4.8% | 6.1% | |
Female, lymphoma | 8.3% | 10.8% | 14.5% |
Analyzed as female lymphoma versus other.